RCT in 88 patients with IBD: double-dose (40 μg) HBV vaccine gave higher adequate response (anti-HBs >10 IU/L) than standard dose (88.4% vs 55.6%, p=0.001); the difference was significant in those on immunosuppression but not those without.
RCTn = 88
Singh et al. Clinical Trial: Immunogenicity of Double-Dose Versus Standard-Dose of Hepatitis B Virus Vaccine in Inflammatory Bowel Disease